Loading...
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial
OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...
Na minha lista:
| Udgivet i: | J Clin Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/ https://ncbi.nlm.nih.gov/pubmed/26214725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|